In regard to the question posed in the title of this review, the answer is mixed. IPN is possible today but only on a limited basis and at high cost with uncertain benefit. A 1.1% amino acid dialysis solution for IPAA therapy is available in several European countries but has not yet been approved for use in the United States. When it becomes more widely available, IP AA should become an important tool, along with other types of therapy, for use in the maintenance of good nutritional status in PDpatients.
FentonS.S.A., JohnstonN., DelmoreT.Nutritional assessment of continuous ambulatory peritoneal dialysis patients.Trans Am Soc Artif Intern Organs1987; 33: 650–3.
2.
YoungG.A., KoppleJ.D., LindholmB.Nutritional assessment of continuous ambulatory peritoneal dialysis patients. An international study.Am J Kidney Dis1991; 17: 462–71.
3.
MarckmannP.Nutritional status of patients on hemodialysis and peritoneal dialysis.Clin Nephrol1988; 29: 75–8.
4.
SaluskyI.B., FineR.N., NelsonP., BlumenkrantzM.J., KoppleJ.D.Nutritional status of children undergoing continuous ambulatory peritoneal dialysis.Am J Clin Nutr1983; 38: 599–611.
5.
PollockC.A., AllenB.J., WardenR.A.Total body nitrogen by neutron activation in maintenance dialysis.Am J Kidney Dis1990; 16: 38–45.
6.
WilliamsP., KayR., HarrisonJ.Nutritional and anthropometric assessment of patients on CAPD over one year; contrasting changes in total body nitrogen and potassium.Perit Dial Bull1981; 1: 82–9.
7.
NelsonE.E., HongC.D., PesceA.L.Anthropometric norms for the dialysis population.Am J Kidney Dis1990; 16: 32–7.
8.
TeehanB.P., SchleiferC.R., BrownJ.M.Urea kinetic analysis and clinical outcome on CAPD: a five-year longitudinal study. In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G., eds. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Bulletin, 1990; 6: 181–5.
9.
AvramM.M., GoldwasserP., ErroaM.Predictors of survival in continuous ambulatory peritoneal dialysis patients: the importance of pre albumin and other nutritional and metabolic markers.Am J Kidney Dis1994; 23: 91–8.
10.
KeshaviahP., ChurchillD.N., ThorpeK.Impact of nutrition on CAPD mortality (Abstract).Kidney Int1994; 5: 494.
11.
BlumenkrantzM.J., KoppleJ.D., MoranJ.K., CoburnJ.W.Metabolic balance studies and dietary protein requirements in patients undergoing continuous ambulatory peritoneal dialysis.Kidney Int1982; 21: 849–61.
12.
BergströmJ., FürstP., AlvestrandA., LindholmB.Protein and energy intake, nitrogen balance, and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis.Kidney Int1993; 44: 1048–57.
LindholmB., KarlanderS.G., NorbeckH.E., BergströmJ.Hormonal and metabolic adaptation to the glucose load of CAPD in non-diabetic patients. In: KeenH., LegrainM., eds. Prevention and treatment of diabetic nephropathy.Boston: MTP Press, 1983: 353–9.
15.
KoppleJ.D., HirschbergR.Nutrition and peritoneal dialysis. In: MitchW.E., KlahrS., eds. Nutrition and the kidney.Boston: Little, Brown1993; chap 12: 290–313.
BlumenkrantzM.J., GahlG.M., KoppleJ.D.Protein losses during peritoneal dialysis.Kidney Int1981; 19: 593–602.
19.
BannisterD.K., AcchiardoS.R., MooreL.W.Nutritional effects of peritonitis in continuous ambulatory peritoneal dialysis (CAPD) patients.J Am Diet Assoc1987; 87: 53–6.
20.
Di PaoloN., SacchiG., De MiaM.Does dialysis modify the peritoneal structure? In: la GrecaG., ChiaromonteS., eds. Peritoneal dialysis.Milan: Wichtig, 1985: 11–24.
21.
TwardowskiZ., KhannaR., NolphK.Osmotic agents and ultrafiltration in peritoneal dialysisNephron1986; 42: 93–101.
22.
GjessingJ.Addition of amino acids to peritoneal dialysis fluid.Lancet1968; 2: 812.
23.
By hamL., CieriE.Intraperitoneal nutrition.Contemp Dial Nephrol1991; Oct: 12–14.
OreopoulosD.G., CrasswellerP., KatirtzoglouA.Amino acids as an osmotic agent (instead of glucose) in continuous ambulatory peritoneal dialysis. In: LegrainM., ed. Proceedings of an International Symposium.Amsterdam: Excerpta, 1980.
26.
OreopoulosD.G., MarlissE., AndersonG.H.Nutritional aspects of CAPD and the potential use of amino acid containing dialysis solutions.Perit Dial Bull1983; 3(Suppl): S10–12.
27.
WilliamsP., MarlissE.B., AndersonG.H.Amino acid absorption following intraperitoneal administration in CAPD patients.Perit Dial Bull1982; 2: 124–30.
28.
GoodshipT.J., LloydS., McKenzieP.W.Short-term studies on the use of amino acids as an osmotic agent in continuous ambulatory peritoneal dialysis.Clin Sci1987; 73: 471–8.
29.
HanningR.M., BalfeJ.W., ZlotkinS.H.Effectiveness and nutritional consequences of amino acid-based vs. glucose-based dialysis solutions in infants and children receiving CAPD.Am J Clin Nutr1987; 46: 22–30.
30.
HanningR.M., BalfeJ.W., ZlotkinS.H.Effect of amino acid containing dialysis solutions on plasma amino acid profiles in children with chronic renal failure.J Pediatr Gastroentrol Nutr1987; 6: 942–7.
31.
OrenA., WuG., AndersonG.H.Effective use of amino acid dialysate over four weeks in CAPD patients.Perit Dial Bull1983; 3: 66–73.
32.
SchillingH., WuG., PetitJ.Effects of prolonged CAPD with amino-acid-containing solutions in three patients. In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G., eds. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Bulletin, 1985; 1: 49–55.
33.
PedersenF.B., DragsholtC., LaierE.Alternate use of amino acid and glucose solutions in CAPD.Perit Dial Bull1985; 5: 215–18.
34.
DombrosN., PrutisK., TongM.Six-month over night intraperitoneal amino acid infusion in continuous ambulatory peritoneal dialysis patients. No effect on nutritional status.Perit Dial Int1990; 10: 79–84.
35.
YoungG.A., DibbleJ.B., HobsonS.M.The use of an amino acid-based CAPD fluid over 12 weeks.Nephrol Dial Transplant1989; 4: 285–92.
36.
BrunoM., BagnisC., MaragellaM.CAPD with an amino acid dialysis solution: a long-term cross-over study.Kidney Int1989; 5: 1189–94.
37.
ArfeenS., GoodshipT.H., KirkwoodA.The nutritional/metabolic and hormonal effects of 8 weeks of continuous ambulatory peritoneal dialysis with a 1 % amino acid solution.Clin Nephrol1990; 33: 192–9.
38.
RenzoS., BeatriceD., GiuseppeL.CAPD in diabetics: use of amino acids. In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G., eds. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Bulletin, 1990; 6: 53–5.
39.
MaurerO., SaxenhoferH., JaegerPhImpact of six month overnight peritoneal dialysis with 1% amino acid solution on body composition in patients with terminal renal failure (Abstract).J Am Soc Nephrol1991; 2: 365.
40.
KoppleJ.D., BernardD., MessanaJ.Treatment of malnourished CAPD patients with an amino acid based dialysate.Kidney Int1995; 47: 1148–57.
41.
JonesM., HamburgerR., Chary tanC.Treatment of malnutrition in peritoneal dialysis (PD) patients with a 1.1% amino-acid (AA) dialysis solution (Abstract).Perit Dial Int1995; 15: S42.
42.
FallerB., AparicioM., FaictD.Clinical evaluation of an optimised 1.1% amino acid solution for peritoneal dialysis.Nephrol Dial Transplant (in press).
43.
CanepaA., PerfumoF., CarreaA.Long-termeffect of amino-acid dialysis solution in children on continuous ambulatory peritoneal dialysis.Pediatr Nephrol1991; 5: 215–19.
44.
QamarI.U., LevinL., BalfeJ.W.Effects of 3-month amino acid dialysis compared to dextrose dialysis in children on continuous ambulatory peritoneal dialysis.Perit Dial Int1994; 14: 34–41.
45.
LowrieE., KaminskiM.V., WalkerP.Changes in serum albumin levels of peritoneal dialysis patients receiving 4 weeks of intraperitoneal nutrition therapy. 34th Annual Meeting. American College of Nutrition, Chicago, IL, 1993.
46.
OkamuraK., YamaguchiJ., NakahamaH.The effects of adding essential amino acids to the dialysis solution of continuous ambulatory peritoneal dialysis patients. In: MackawaM., NolphK.D., KishimotoT., MoncriefJ.W., eds. Machine Free Dialysis for Patient Convenience: The Fourth ISAO Official Satellite Symposium on CAPD.Cleveland: ISAO Press, 1984.
47.
HondaM., YasunoriK., OsamuH.Effect of shortterm essential amino acid-containing dialysate in young children on CAPD.Perit Dial Int1991; 11: 76–80.
48.
RubinJ., GarnerT.Positive nitrogen balance after intraperitoneal administration of amino acids in 3 patients.Perit Dial Int1994; 14: 223–6.
49.
MontoyaS.F.Serum albumin benefit to a CAPD patient using intraperitoneal nutrition (IPN) over a six-month period (Abstract).Perit Dial Int1994; 14: S64.
50.
MontoyaS.F., JuradoJ.L.Clinical results of intraperitoneal amino acid administration in hospitalized CAPD patients (Abstract).J Am Soc Nephrol1991; 2: 366.
51.
MontoyaS.F., JuradoJ.L., CantuG.Intraperitoneal amino acid infusion in a CAPD patient (Abstract).Perit Dial Int1991; 11: 141.
SteinhauerH.B., Lubrich-BirkerI., KlutheR.Effect of amino acid based dialysis solution on peritoneal permeability and prostanoid generation in patients undergoing continuous ambulatory peritoneal dialysis.Am J Nephrol1992; 12: 61–7.
54.
HofferL.J.Starvation. In: ShilsM.E., YoungV.R., eds. Modern nutrition in health and disease.7th ed.Philadelphia: Lea and Febiger, 1988: 774–94.
55.
KoppleJ.D.Uses and limitations of the balance technique.J Parenter Enteral Nutr1987; 11: 79S–85S.
56.
AndersonG.H., PatelD.G., JeejeebhoyK.N.Design and evaluation by nitrogen balance and blood aminograms of an amino acid mixture for total parenteral nutrition of adults with gastrointestinal disease.J Clin Invest1974; 53: 904–12.
57.
Subcommittee on the Tenth Edition of the RDAs Food and Nutrition Board, Commission on Life Sciences, National Research Council.Recommended Dietary Allowances.10th ed.Washington, DC: National Academy Press, 1989: 52–77.
58.
LukaskiH.C.Methods for the assessment of human body composition.Am J Clin Nutr1987; 46: 537–56.
59.
JensenT.G., EnglertD.M., DudrickS.J.Nutritional assessment: a manual for practitioners.Norwalk Connecticut: Appleton-Century -Crofts, 1983: 176–80.
60.
VeheK., BrownR.O., MooreL.W.The efficacy of nutrition support in infected patients with chronic renal failure.Pharmacotherapy1991; 11: 303–7.
61.
LindholmB., WerynskiA., TranaeusA.Kinetics of peritoneal dialysis with amino acids as osmotic agents. In: NoseY., KjellstrandC., IvanovichP., eds. Progress in artificial organs, 1985.Cleveland: ISAO Press, 1986: 284–8.
62.
YoungG.A., DibbleJ.B., TaylorA.E.A longitudinal study of the effects of amino acid-based CAPD fluid on amino acid retention and protein losses.Nephrol Dial Transplant1989; 4: 900–5.
63.
GoodshipT.H.J.Correction of acidosis in humans with CRF decreases protein degradation and amino acid oxidation.Am J Physiol1993; 265 (Endocrinol Metab 28): E230–5.
64.
MuskM., AndersonH., OreopoulosD.Effects of amino acid dialysate on appetite in CAPD patients. In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G., eds. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Bulletin, 1992; 8: 153–6.
65.
IkizlerT., WingardR., BreyerJ.Short-termeffects of recombinant human growth hormone in CAPD patients.Kidney Int1994; 46: 1178–83.
66.
KangD.H., LeeS.W., KangS.W.Recombinant human growth hormone (rhGH) improves nutritional status of undernourished adult CAPD patients (Abstract).J Am Soc Nephrol1994; 5: 494.
67.
PengS., FouqueD., KoppleJ.Insulin-like growth factor 1 (IGF-l) causes anabolism in malnourished CAPD patients (Abstract).J Am Soc Nephrol1993; 4: 414.
68.
DratwaM., VladutiuD., KellerJ.Nutritional support with Nutrineal® (N) for CAPD peritonitis (Abstract).Perit Dial Int1995; 15: S39.
